EU Health Award

EU Health Award Jury


The Jury of the 2018 EU Health Award for NGOs working to prevent tobacco use has been appointed and is currently evaluating the applications received, according to the criteria established by the Steering Group on Promotion and Prevention. The Jury is composed of 1 chair and 7 jury members with expertise in the field of European public health. Some Jury members have specific expertise on the prevention of tobacco use.

The European Commission will award the prize based on the Jury's decision. The Jury will establish a shortlist of projects that are being considered as good practices from the candidate submissions for the 2018 EU Health Award for NGOs. The shortlisted candidates will be announced in the EU Health Award website. This announcement will also be reported on Twitter (@EU_Health) and the EU Health Policy Platform.

The shortlisted NGOs and the Jury will be invited to attend the EU Health Policy Platform Annual Meeting in November 2018, in Brussels. At this event, Commissioner Vytenis Andriukaitis will present the 2018 EU Health Award for NGOs working to prevent tobacco use, awarding a first-, second- and third-place winner.

Please be aware that announced date may be subject to change.



Chair - Isabel de la Mata

Dr Isabel de la Mata is currently the Principal Adviser for Health and Crisis Management in the European Commission. Previously, she worked as Counsellor for Health and Consumers at the Permanent Representation of Spain to the EU, as Deputy Director General for Health Planning at the Spanish Ministry of Health and as Advisor to the Vice-Minister of Health. In addition, she has been a member of the Standing Commission of the Regional Committee, the Pan-American Health Organisation, the Inter-American Development Bank and the Spanish Agency for International Cooperation. Dr de la Mata graduated in Medicine and Surgery at the University of the Basque Country in 1983 and holds post-graduate degrees from the University of Leuven and Paris. She is a specialist in Preventive Medicine and Public Health.


Alexis Goosdeel

Director, European Monitoring Centre for Drugs & Drug Addiction (EMCDDA)

Mr Alexis Goosdeel joined the EMCDDA in 1999 as a project manager in the area of EU enlargement and international relations. From 2005, he headed the agency’s Reitox and international cooperation unit. In this capacity, he played a central role in coordinating a network of 30 national drug monitoring centres; preparing EU candidate and potential candidate countries for membership in the EMCDDA; developing cooperation with neighbouring countries to the EU and nurturing relations with countries beyond the Union (Central Asia, Russia, Latin America). Much of his 30-year career was spent working in the field of health at national, European and international level.
He holds a Master’s degree in clinical psychology from Université Catholique de Louvain and a special diploma in advanced management from ICHEC Brussels Management School. He is proficient in six languages: French (mother tongue); English, Spanish, Greek, Portuguese and Dutch.

Andrzej Jan Rys

Andrzej Jan Rys, a medical doctor specialised in radiology and public health and a graduate of Jagiellonian University, Krakow (Poland), is the current Director responsible for health systems, medical products and innovation at the Directorate-General for Health and Food Safety in the European Commission. He is member of Innovative Medicines Initiative (IMI) Governing Board and alternate member of the European Medicines Agency (EMA) Board.
Until 2011, Andrzej Rys was Director for health systems and products at the Directorate-General for Health and Food Safety and until 2006, Director for public health and risk assessment at the Directorate-General for Health and Consumers in the European Commission.
Andrzej Rys was founder and Director of the Center for Innovation and Technology Transfer and of the School of Public Health at Jagiellonian University (Krakow, Poland). From 1999 to 2002, he was the Deputy Minister of Health in Poland and a member of the Polish accession negotiators team.

Charmaine Gauci

Charmaine Gauci is the Superintendent of Public Health within the Ministry for Health in Malta, with the broad responsibility of overseeing public health to safeguard and enhance citizens' health. She had previously served as Director of the Health Promotion and Disease Prevention Directorate for nine years.
She is a medical doctor and pursued her studies with MSc Public Health Medicine, the European Programme in Epidemiological Training and PhD in epidemiology. Dr Gauci is a Prince practitioner in project management, a fellow of the UK Royal Society for Public Health and a fellow of the UK Faculty of Public Health. Dr Gauci is a senior lecturer at the University of Malta and has served as president of the Malta Association of Public Health Medicine for four years.


Elke Anklam

Elke Anklam is a chemist specialised in food, organic and radiation chemistry. After obtaining her PhD from the University Hamburg (Germany), she worked in various European Research Institutions and was a Teaching Professor at the Applied University of Fulda (Germany).
Since 1991, she has been working at the European Commission's Joint Research Centre (EC-JRC). Since 2006, she has been serving as a Director at the JRC. At present, she is the Director of the JRC-Geel site and Director of JRC Directorate F: Health, Consumers & Reference Material, located at the JRC-Geel and JRC-Ispra site.


Demosthenes B. Panagiotakos

Demosthenes Panagiotakos is a Professor of Biostatistics, Research Methods and Epidemiology. Since 2016, he has served as the vice Rector of Financial Affairs, Research and Development of the Harokopio University in Athens. He received 3 Young Investigators’ National and International Awards and 3 Scholarships (2 National, 1 EU) and many awards from various scientific societies. He has also served as an evaluator for 17 national and international organisations and has actively participated in campaigns against tobacco use and substances, as well as exposure to environmental tobacco smoking. Prof Panagiotakos is currently a Member of the European Commission's Scientific Committee of Health, Environment and Emerging Risks (2016-2021). He is also a Board Member of the National Nutrition Policy Committee and has served on the boards of the Scientific Council of the Hellenic Food Authority and the National Council of Public Health.

Kari Paaso

Mr Kari Paaso works with the Finnish Ministry of Social Affairs and Health. He heads the unit that deals with policy and legal matters on tobacco, alcohol, illicit drugs, gambling, injury prevention and domestic violence. Mr Paaso has been a member of the FCTC Bureau, where he represents the WHO EURO region, since 2016.
Mr Paaso started in the Ministry in 1996. In 2002, he moved to the European Commission, DG SANCO, to work on tobacco- and alcohol-related files. His main area of work in the Commission was the preparation and finalisation of legal files related to tobacco. He was a member of the Commission team in the FCTC negotiations in 2002 and in the final round in 2003.
From the Commission he moved to the WHO Regional Office for Europe in 2006 to work as an Acting Programme Manager for tobacco and alcohol policy.

Kristina Mauer-Stender

Kristina Mauer-Stender graduated from Strasbourg in 1996 with a Masters in International Public Law and Human Rights Comparative Law.
She worked at the UN High Commissioner for Refugees and the UN Development Program before joining the WHO in 2003, starting out as a Technical Officer in Tobacco Control at the WHO Regional Office for Europe in Copenhagen. Kristina is now the Program Manager where she advises policy makers from health and other sectors on tobacco control policies in line with the WHO FCTC, international evidence and good practices. Kristina works daily with policy makers and other cross-societal partners in around 25 countries in the European Region. She leads the work of the WHO European Office on realising the vision of a tobacco-free European Region following up no the recently adopted Roadmap of actions to strengthen the implementation of the WHO FCTC in the European Region 2015-2025, which 53 Ministers of Health committed to in 2015.